Capital Research Global Investors Organon & Co. Transaction History

Capital Research Global Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $15,133 - $18,594	-478 Reduced 0.66%	71,425 $2.41 Million
Q1 2022 May 19, 2022	BUY	$30.45 - $39.36 $2.19 Million - $2.83 Million	71,903 New	71,903 $2.51 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $2.17 Million - $2.81 Million	-71,390 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $3.79 Million - $4.91 Million	-132,129 Reduced 64.92%	71,390 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $2,376 - $2,958	-83 Reduced 0.04%	203,519 $6.67 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $5.79 Million - $7.74 Million	203,602 New	203,602 $6.16 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.